Skip to main content
CME and General Info
Registration Desk Hours
Accreditation
CE/CME Evaluations
FAQs
Agenda
PAINWeek 101 Suggested Agenda
Full Schedule
Browse By Date
Poster Abstracts
Monday, September 5, 2022
Tuesday, September 6, 2022
Wednesday, September 7, 2022
Thursday, September 8, 2022
Friday, September 9, 2022
Browse By Title
Browse By Faculty
Sort by Track
Exhibit Hall
Exhibitors
Floor Plan
Sponsored Programs
Faculty
Abstracts
Need Help?
Toggle navigation
Login
Search
Home
CME and General Info
Registration Desk Hours
Accreditation
CE/CME Evaluations
FAQs
Agenda
PAINWeek 101 Suggested Agenda
Full Schedule
Browse By Date
Poster Abstracts
Monday, September 5, 2022
Tuesday, September 6, 2022
Wednesday, September 7, 2022
Thursday, September 8, 2022
Friday, September 9, 2022
Browse By Title
Browse By Faculty
Sort by Track
Exhibit Hall
Exhibitors
Floor Plan
Sponsored Programs
Faculty
Abstracts
Need Help?
Tweets by PAINWeek 2022
Icon Legend
This session is not in your agenda.
This session is in your agenda. Click to remove it
Back
Favorite
0
Like
Facebook
Tweet
Print
Stephen B. Shrewsbury, MD
Chief Medical Officer
Impel Pharmaceuticals
Seattle, Washington
Presentation(s):
Poster Number-3 - Early Prediction of Response to INP104 for the Acute Treatment of Migraine
Poster Abstracts
Poster Number-1 - Exploratory Efficacy of INP104 in Migraine Patients By Prior Treatment
Poster Abstracts
Poster Number-2 - Exploratory Efficacy of INP104 in Patients Using Concomitant Preventive Migraine Medications
Poster Abstracts
Poster Number-4 - Improvements in Productivity and Disability With INP104 as Assessed by the Migraine Disability Assessment Scale (MIDAS): Results From the Phase 3 STOP 301 Study
Poster Abstracts
